MD Medical Group announces board of directors changes
|Download file (248 K)|
06December 2019, Moscow – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG),), a leading Russian private healthcare provider, today announces changes in its Board of Directors.
Tatyana Lukina and Tony Mayer were appointed as Independent Non-Executive Directors for the vacant positions in BoD. The changes came into force on 06 December 2019.
Ms Tatiana Lukina brings to the Company her 18 years of experience in finance, business restructuring and project management in a wide range of industries.
Since 2016 Ms Lukina has been working as a CFO at GAME INSIGHT, a global mobile game developing company. Tatiana's career has commenced in KPMG, where during 10 years she participated and led projects in audit, capital markets transactions (IPO, SPO, Eurobons) in international stock exchanges, debt restructuring for major Russian companies, M&A transaction services in different countries. After that Tatiana worked in the Portfolio Asset Management department at ALFA Group, represented shareholders in Boards and Committees of ALFA bank (Russia, Ukraine, Kazakhstan) and Rosvodokanal. In 2015-2016 Tatiana as a co-leader of finance headed an IPO preparatory project at OZON.ru, a leading on-line retailer in Russia.
Ms Lukina graduated from the Financial Academy of the Russian Government with a 1st-class honour degree in Finance, Business Appraisal and Turnaround Management and then finished her PhD there.
Since 2006 Tatiana is a member of the Association of Certified Chartered Accountants (ACCA) in the UK, successfully passed exams for a Russian Audit License.
Mr Tony Maher brings to the Group more than 40 years of experience in the consumer sector.
Mr Maher’s other current appointments include the positions of Chairman at Progress, Russia’s largest baby food company, since 2012; Chairman at LPQ Russia Limited, a restaurant chain operator, since 2015; Board member at Detsky Mir, the largest children's goods retailer in Russia and the CIS, since 2018; and Director of Da Vinci Capital, a leading independent investment manager, since 2012.
Mr Maher previously served as CEO of Wimm-Bill-Dann, the leading producer of dairy, baby food and beverage products in Russia, and held various positions at Coca-Cola in a number of countries.
Mr Maher holds a B.A. Honours degree in Management from The National Council for Education in Ireland.
Mark Kurtser, CEO of MD Medical Group, said:
“We are pleased to announce that two new members have joined the Board as independent directors and are confident that their extensive experience in managing major projects in various spheres will contribute to the further development of the Company”.
For further information please contact:
MD Medical Group Investments Plc
Tel: +7 495 331 41 20
Tom Blackwell: +7 919 102 9064
Sergii Pershyn: +1 929 855 8188
About MD Medical Group
MD Medical Group is a leading provider in the highly attractive Russian private healthcare service market. The company manages 40 modern healthcare facilities, including 6 hospitals and 34 out-patient clinics in Moscow and the Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk, Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula, Kazan, Vladivostok and Krasnodar.
The Company’s shares have been listed on the London Stock Exchange (LSE ticker “MDMG”) in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
This press release contains forward looking statements, which are based on the Company’s current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company’s ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements. No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.
2020 2019 2018 2017 2016 2015 2014 2013 2012